Repligen (RGEN) Posts Q4 Loss of 1c/Share
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $131.50 +4.06%
Revenue Growth %: +10.7%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +10.7%
Financial Fact:
Selling, general and administrative: 7.13M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $15.4 million versus the consensus estimate of $14.7 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Odysight.AI Inc. (ODYS) PT Lowered to $6 at Benchmark
- Absci, FuelCell Energy surge premarket; Cerebras, FedEx tumble
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
